Roth Capital: Buy The Dips In Bluebird Bio
July 13, 2015 at 14:55 PM EDT
In a report published Monday, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on shares of bluebird bio Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.